Symbion parent EBOS has increased net profit, despite losing $251 million in revenue as a result of PBS reforms and reduced hepatitis C sales.

The New Zealand-based group reported an underlying net

The owner of a small Queensland pharmacy is recruiting fellow independents to pool their buying power in negotiations with wholesalers.

Steve Flavel, of Brisbane, says he has combined forces with

Sigma Healthcare says it will weigh up the pros and cons of independence before considering a merger proposal from Australian Pharmaceutical Industries (API).

API proposed in December that it would

The TerryWhite Chemmart pharmacy network is now fully owned by EBOS, the parent company of Symbion.

The acquisition of the minority shares in the Terry White Group was completed on Christmas Eve,

The Federal Government has moved to restrict exclusive direct supply through new CSO wholesale contracts.

CSO wholesalers will be unable to enter exclusive direct supply arrangements after 30 June

In a major win for pharmacies and wholesalers, AstraZeneca has backtracked on its direct-supply strategy.

From February, pharmacies will be able to buy all the company’s products from their preferred

The Chemist Warehouse Group (CWG) and Symbion’s parent company, EBOS, have formally signed their five-year distribution agreement.

This confirms that EBOS will become the exclusive wholesale

DHL CEO Saul Resnick has come out strongly in support of exclusive supply as an efficient alternative to CSO wholesalers.

Facing up to CSO wholesaler protagonist Mark Hooper during a panel discussion

The planned merger between generic manufacturers Arrow and Apotex has been given the all-clear by Australia’s competition watchdog.

The ACCC says it won’t fight the merger because there is no

The hot topics on Pharmacy News this week included the prescription drug dilemma, the switch of biosimilars and the big year for wholesalers. 

Prescription drug dilemma

Let me get this straight,